002038.SZ
双鹭药业
SZSE · Healthcare · C 制造业 · CN
CNY 6.37
−10.03%Margins
Gross margin
63.3%
EBITDA margin
-19.0%
EBIT margin
-72.9%
Net margin
-81.0%
FCF margin
51.5%
-9.4%
Return on equity
-8.2%
Return on assets
-8.5%
Return on invested capital
0.10x
Asset turnover
CNY 372.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026